肺肿瘤经皮冷冻消融后主动与被动复温对咯血发生率、分级及发生时间的影响
本研究回顾性纳入47例患者共60次CT引导下肺肿瘤冷冻消融(95个肿瘤),比较三冻循环方案中最终复温采用主动(电加热、无氦)与被动复温对咯血的影响。
要点
- 主动复温可显著降低肺冷冻消融后咯血发生率(19% vs 64%)。
- 主动复温组咯血分级更轻且发生时间延迟,多发生于恢复期之后。
- 气胸、血胸发生率及局部肿瘤控制两组无差异。
关键影像表现/征象
- 咯血总发生率为43%(26/60次),其中85%(22/26)为CTCAE 1级自限性咯血。
诊断标准与关键数值
- 咯血、气胸、血胸按CTCAE 5.0版分级,咯血>1级为较重结局。
临床应用与阅片要点
- 在肺肿瘤三冻循环冷冻消融中,最终复温采用主动复温可减少咯血并减轻其严重程度。
- 主动复温使咯血发生延迟至恢复期之后,阅片和随访时应关注延迟出现的咯血症状。
- 主动复温不增加气胸、血胸风险,也不影响局部肿瘤控制,可作为提高安全性的操作策略。
局限性
- 回顾性单中心研究,样本量较小(60次消融),可能存在选择偏倚。
- 主动与被动复温分组非随机,尽管采用多变量模型调整,仍可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Hemoptysis is common after percutaneous image-guided cryoablation of pulmonary tumors. OBJECTIVE. The purpose of our study was to evaluate the effect of a final active thaw on the incidence, grade, and onset of hemoptysis after percutaneous cryoablation of pulmonary tumors. METHODS. This retrospective cohort study included 60 consecutive CT-guided cryoablation sessions targeting 95 pulmonary tumors in 47 patients from March 2017 to September 2020. The final thaw of a triple-freeze protocol was active (electrical, helium-free) in 27 of 60 sessions (45%, active group) and passive in 33 of 60 sessions (55%, passive group). The incidence, onset, and management of hemoptysis were recorded using prospectively collected data. Hemoptysis, pneumothorax, and hemothorax within 30 days after ablation were graded according to Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. The volume of immediate posttreatment changes on CT was quantified using semiautomated segmentation. Outcomes were compared between groups using generalized estimating equation models. A parsimonious multivariable model for hemoptysis incidence was developed using purposeful selection of predefined covariates followed by bootstrap resampling. Local tumor control was compared between groups using the Kaplan-Meier method and log-rank testing. RESULTS. Hemoptysis occurred after 26 of 60 (43%) sessions and was self-limited (CTCAE grade 1) in 22 of 26 (85%) sessions. The incidence of hemoptysis was lower in the active group than in the passive group (19% vs 64%, respectively; p = .002). The odds of hemoptysis adjusted for immediate posttreatment changes were 92% lower in the active group (odds ratio [OR], 0.08 [95% CI, 0.02-0.37]; p = .004). The odds of hemoptysis greater than grade 1 were 79% lower in the active group (OR, 0.21 [95% CI, 0.07-0.64]; p = .006). In the active group, the onset of hemoptysis was significantly delayed (OR, 0.75 [95% CI, 0.61-0.91]; p = .005). Pneumothorax (p = .60), hemothorax (p = .84), and local tumor control (p = .77) did not differ between groups. CONCLUSION. Active thaw after the final freeze reduces the incidence and grade of hemoptysis and delays the onset of hemoptysis after percutaneous cryoablation of pulmonary tumors without adversely affecting other procedural complications and local tumor control. CLINICAL IMPACT. Active thaw after the final freeze improves the safety profile of triple-freeze cryoablation of pulmonary tumors by reducing the incidence and grade of hemoptysis and by delaying the onset of hemoptysis beyond the immediate recovery period.
引用
- Wrobel MM, Bourgouin PP, Abrishami Kashani M, et al. Active Versus Passive Thaw After Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis. AJR Am J Roentgenol. 2021. PMID: 34008999. doi:10.2214/AJR.21.25872
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。